التفاصيل البيبلوغرافية
| العنوان: |
Potential of Neuroinflammation-Modulating Strategies in Tuberculous Meningitis: Targeting Microglia. |
| المؤلفون: |
Huan-Jun Lu1, Daji Guo2, Qian-Qi Wei3 infection0522@163.com |
| المصدر: |
Aging & Disease. Jun2024, Vol. 15 Issue 3, p1255-1276. 22p. |
| مصطلحات موضوعية: |
*NEUROINFLAMMATION, *TUBERCULOUS meningitis, *MICROGLIA |
| مستخلص: |
Tuberculous meningitis (TBM) is the most severe complication of tuberculosis (TB) and is associated with high rates of disability and mortality. Mycobacterium tuberculosis (M. tb), the infectious agent of TB, disseminates from the respiratory epithelium, breaks through the blood-brain barrier, and establishes a primary infection in the meninges. Microglia are the core of the immune network in the central nervous system (CNS) and interact with glial cells and neurons to fight against harmful pathogens and maintain homeostasis in the brain through pleiotropic functions. However, M. tb directly infects microglia and resides in them as the primary host for bacillus infections. Largely, microglial activation slows disease progression. The non-productive inflammatory response that initiates the secretion of pro-inflammatory cytokines and chemokines may be neurotoxic and aggravate tissue injuries based on damages caused by M. tb. Host-directed therapy (HDT) is an emerging strategy for modulating host immune responses against diverse diseases. Recent studies have shown that HDT can control neuroinflammation in TBM and act as an adjunct therapy to antibiotic treatment. In this review, we discuss the diverse roles of microglia in TBM and potential host-directed TB therapies that target microglia to treat TBM. We also discuss the limitations of applying each HDT and suggest a course of action for the near future. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder